120
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population

&
Pages 377-384 | Published online: 13 Jul 2017

References

  • HewitsonPGlasziouPWatsonETowlerBIrwigLCochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an updateAm J Gastroenterol200810361541154918479499
  • ScholefieldJHMossSMManghamCMWhynesDKHardcastleJDNottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-upGut20126171036104022052062
  • ShaukatAMonginSJGeisserMSLong-term mortality after screening for colorectal cancerN Engl J Med2013369121106111424047060
  • ImperialeTFRansohoffDFItzkowitzSHTurnbullBARossMEColorectal Cancer Study GroupFecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk populationN Engl J Med2004351262704271415616205
  • BrennerHTaoSSuperior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopyEur J Cancer201349143049305423706981
  • LeeJKLilesEGBentSLevinTRCorleyDAAccuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysisAnn Intern Med2014160317124658694
  • ImperialeTFRansohoffDFItzkowitzSHMultitarget stool DNA testing for colorectal-cancer screeningN Engl J Med2014370141287129724645800
  • LinJSPiperMAPerdueLAScreening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task ForceJAMA2016315232576259427305422
  • AhlquistDAMulti-target stool DNA test: a new high bar for noninvasive screeningDig Dis Sci201560362363325492503
  • HundtSHaugUBrennerHComparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detectionAnn Intern Med2009150316216919189905
  • ChenHWernerSBrennerHFresh vs frozen samples and ambient temperature have little effect on detection of colorectal cancer or adenomas by a fecal immunochemical test in a colorectal cancer screening cohort in GermanyClin Gastroenterol Hepatol Epub20161026
  • R-Project [homepage on the Internet]The R Project for Statistical ComputingVienna, Austria Available from: http://www.R-project.org/Accessed March 31, 2016
  • LeviZBirkenfeldSVilkinAA higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility studyInt J Cancer2011128102415242420658527
  • Parra-BlancoAGimeno-GarcíaAZQuinteroEDiagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screeningJ Gastroenterol201045770371220157748
  • ChiangTHLeeYCTuCHChiuHMWuMSPerformance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tractCMAJ2011183131474148121810951
  • BrennerHWernerSChenHMultitarget stool DNA for colorectal-cancer screeningN Engl J Med20143712184185
  • RubecaTRapiSConfortiniMEvaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening settingInt J Biol Markers200621315716117013797
  • FaivreJDancourtVDenisBComparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancerEur J Cancer201248162969297622572481
  • ZuberoMBArana-ArriEPijoanJIPopulation-based colorectal cancer screening: comparison of two fecal occult blood testsFront Pharmacol2014417524454288
  • SantareDKojaloIHuttunenTImproving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit useEur J Gastroenterol Hepatol201527553654325806603
  • LevinTRJamiesonLBurleyDAReyesJOehrliMCaldwellCOrganized colorectal cancer screening in integrated health care systemsEpidemiol Rev20113310111021709143
  • StegemanIvan DoornSCMundtMWParticipation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screeningCancer Epidemiol201539338839325910865
  • JensenCDCorleyDAQuinnVPFecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort studyAnn Intern Med2016164745646326811150
  • Lansdorp-VogelaarIKuntzKMKnudsenABWilschutJAZauberAGvan BallegooijenMStool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysisAnn Intern Med2010153636837720855801
  • Lansdorp-VogelaarIKnudsenABrennerHCost-effectiveness of colorectal cancer screeningEpidemiol Rev2011338810021633092
  • SharpLTilsonLWhyteSCost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopyBr J Cancer2012106580581622343624
  • DinhTLadabaumUAlperinPCaldwellCSmithRLevinTRHealth benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancerClin Gastroenterol Hepatol20131191158116623542330
  • LejeuneCLe GleutKCottetVThe cost-effectiveness of immunochemical tests for colorectal cancer screeningDig Liver Dis2014461768124012177
  • LadabaumUAlvarez-OsorioLRöschTBrueggenjuergenBCost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNAEndosc Int Open201422E96E10426135268
  • US Preventive Services Task ForceScreening for colorectal cancer: US Preventive Services Task Force recommendationJAMA2016315232564257527304597
  • HaugUGrobbeeEJLansdorp-VogelaarISpaanderMCKuipersEJImmunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended?Gut20176671262126727006184